Clinical Trials Browser

Withdrawn × INDUSTRY × imgatuzumab × Clear all

NCT04985825 2022-09-13

I-PACE

Phase 2 Withdrawn

Carcinoma, Neoplasms

NCT01702714 2016-11-04

A Study of RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic Disease

Phase 1 Withdrawn

Non-Squamous Non-Small Cell Lung Cancer